- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Ryan Huey: Expansion of Patient Support, Care Key to Improve Value-Based Oncology
There are various areas across different patient care and support perspectives that offer opportunities to improve value-based care in oncology, said Ryan Huey, MD, gastrointestinal medical oncologist at MD Anderson Cancer Center in Houston, Texas.
Patient services across various perspectives such as direct patient care and patient support are areas that health systems can expand upon to improve value-based oncology care, said Ryan Huey, MD gastrointestinal medical oncologist at MD Anderson Cancer Center in Houston, Texas.
Transcript
What actions can health systems take to improve value-based oncology care within their organizations?
I think from a direct patient care perspective, there's a role to think about the expanded use of telemedicine and also potentially, chemotherapy even at home, or certainly closer to where a patient lives as opposed to in a traditional infusion suite or a hospital. From a support services perspective, there's a role to expand a lot of services. Some of these were described in the Oncology Care Model such as social work or nutritional support or navigation, physical therapy, palliative care; these are things that are not traditionally reimbursed in a fee-for-service environment, however, can lead to improved outcomes for patients or reduced costs throughout the patient journey. So, this is an excellent way to also think about expanding the use of value-based care in the oncology space
Understanding TB Symptoms, Spread, Treatment Amid Kansas City Outbreak
February 13th 2025In part 2 of this interview, Michael A. Bernstein, MD, highlights the need for prolonged antibiotics and strong public health measures to combat tuberculosis (TB) at both the individual and population levels.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Evolent’s Wonsettler Sees Outcomes-Based Reimbursement as “A Healthy Tool”
February 7th 2025Terra Wonsettler, PharmD, MBA, vice president of pharmacy for Evolent, discusses the recent HHS OIG report that stemmed from the 2021 FDA approval of aducanumab (Aduhelm) and use of the accelerated approval pathway.
Read More
